SUPN Supernus Stock Quotes

Brandmark of Supernus Corp (SUPN)

Supernus Pharmaceuticals (SUPN) is establishing resilient distribution channels for neurological drugs, leveraging raw material supplier diversification to maintain profitability. This price chart illustrating the changes confirms that the current figure is 29.75. Expanding reach in ADHD therapy offsets stagnation in legacy niches. Simultaneously, Supernus Pharmaceuticals (SUPN) is implementing targeted drug delivery methods to the brain, which minimizes toxicity and enhances the efficacy of epilepsy treatment.

Quote Chart: Supernus Pharmaceuticals (SUPN) for 07/04/2022 - 11/16/2026

Supernus Pharma (SUPN) - metric breakdowns and financial figures

Analysis of all company metrics:supernus.com SUPN
Signature product of Supernus Pharmaceuticals, Inc.

Professional capital evaluates the issuer's profile through the lens of market consensus. The current quote reflects actual trades, serving as the baseline for calculating future growth potential. By analyzing the price trajectory, investors determine the strength of market momentum. For Supernus Pharmaceuticals (SUPN), this price action reflects market expectations regarding the expansion of Qelbree and the success of Parkinson's disease treatments. Price stability confirms the investment reliability of the asset.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price CPRX|Price Chart Denali Therapeutics|Share Price HRMY (Harmony Pharma)|Stock Price BHVN|AMLX - Market Price|trevitherapeutics.com - Stock Quotes|Stock Price Praxis Precision Medicines Inc PRAX|AVXL - Price Chart|Price Performance Chart CBLL (CeriBell EEG)|Prothena Corporation (PRTA) - Price Chart|Market Price Alector Inc. (ALEC)|ANNX (annexonbio.com) - Stock Price|Market Price omeros.com OMER|Stock Price NGNE|Stock Quotes AC Immune ACIU|Voyager Therapeutics Inc - Stock Quotes|Stock Price neumoratx.com NMRA|SCLX - Price Chart|Market Price Tevogen Bio|ACOG: Stock Price|CGTX - Market Chart|Price Chart Inhibikase Pharma|Price Chart SAVA|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel